Cypress Capital Management LLC WY Trims Stake in Colgate-Palmolive (NYSE:CL)

Cypress Capital Management LLC WY lessened its holdings in Colgate-Palmolive (NYSE:CL) by 35.9% in the fourth quarter, according to its most recent filing with the SEC. The institutional investor owned 1,000 shares of the company’s stock after selling 560 shares during the period. Cypress Capital Management LLC WY’s holdings in Colgate-Palmolive were worth $80,000 as of its most recent SEC filing.

A number of other institutional investors have also bought and sold shares of CL. OFI Invest Asset Management bought a new stake in Colgate-Palmolive in the third quarter worth about $25,000. Avion Wealth raised its stake in shares of Colgate-Palmolive by 78.1% during the fourth quarter. Avion Wealth now owns 399 shares of the company’s stock valued at $32,000 after acquiring an additional 175 shares in the last quarter. McGlone Suttner Wealth Management Inc. bought a new stake in shares of Colgate-Palmolive during the fourth quarter valued at approximately $34,000. Kayne Anderson Rudnick Investment Management LLC raised its stake in shares of Colgate-Palmolive by 142.0% during the third quarter. Kayne Anderson Rudnick Investment Management LLC now owns 496 shares of the company’s stock valued at $35,000 after acquiring an additional 291 shares in the last quarter. Finally, West Branch Capital LLC raised its stake in shares of Colgate-Palmolive by 24.0% during the fourth quarter. West Branch Capital LLC now owns 682 shares of the company’s stock valued at $54,000 after acquiring an additional 132 shares in the last quarter. Hedge funds and other institutional investors own 80.41% of the company’s stock.

Analyst Ratings Changes

Several equities analysts recently issued reports on CL shares. Barclays lifted their price objective on shares of Colgate-Palmolive from $82.00 to $84.00 and gave the company an “equal weight” rating in a report on Friday, April 12th. Evercore ISI lifted their price objective on shares of Colgate-Palmolive from $90.00 to $96.00 and gave the company an “outperform” rating in a report on Monday, April 8th. TheStreet raised shares of Colgate-Palmolive from a “c+” rating to a “b+” rating in a report on Friday, January 26th. Wells Fargo & Company lifted their price target on shares of Colgate-Palmolive from $90.00 to $92.00 and gave the stock an “equal weight” rating in a report on Monday. Finally, Royal Bank of Canada lifted their price target on shares of Colgate-Palmolive from $88.00 to $95.00 and gave the stock a “sector perform” rating in a report on Monday. Three research analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $91.38.

Colgate-Palmolive Price Performance

Shares of Colgate-Palmolive stock traded down $0.69 during trading hours on Monday, reaching $90.32. The stock had a trading volume of 2,836,906 shares, compared to its average volume of 4,585,428. The stock’s 50 day moving average is $87.66 and its 200 day moving average is $81.63. The firm has a market capitalization of $74.24 billion, a PE ratio of 28.55, a PEG ratio of 3.42 and a beta of 0.42. Colgate-Palmolive has a twelve month low of $67.62 and a twelve month high of $92.25. The company has a current ratio of 0.42, a quick ratio of 0.28 and a debt-to-equity ratio of 8.59.

Colgate-Palmolive (NYSE:CL) last issued its quarterly earnings data on Friday, April 26th. The company reported $0.86 earnings per share for the quarter, topping analysts’ consensus estimates of $0.82 by $0.04. The business had revenue of $5.07 billion during the quarter, compared to the consensus estimate of $4.96 billion. Colgate-Palmolive had a net margin of 13.22% and a return on equity of 485.40%. The company’s revenue was up 6.2% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.73 earnings per share. Equities analysts expect that Colgate-Palmolive will post 3.5 earnings per share for the current fiscal year.

Colgate-Palmolive Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, May 15th. Investors of record on Monday, April 22nd will be given a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a dividend yield of 2.21%. The ex-dividend date is Friday, April 19th. This is an increase from Colgate-Palmolive’s previous quarterly dividend of $0.48. Colgate-Palmolive’s dividend payout ratio is 63.29%.

Insider Buying and Selling

In related news, insider Jennifer Daniels sold 3,538 shares of the company’s stock in a transaction dated Tuesday, February 20th. The shares were sold at an average price of $84.67, for a total transaction of $299,562.46. Following the completion of the transaction, the insider now owns 59,698 shares in the company, valued at approximately $5,054,629.66. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. In other Colgate-Palmolive news, insider Jennifer Daniels sold 3,538 shares of the stock in a transaction dated Tuesday, February 20th. The shares were sold at an average price of $84.67, for a total value of $299,562.46. Following the completion of the sale, the insider now owns 59,698 shares in the company, valued at approximately $5,054,629.66. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, Director C Martin Harris sold 2,760 shares of the stock in a transaction dated Wednesday, January 31st. The shares were sold at an average price of $84.50, for a total transaction of $233,220.00. Following the completion of the sale, the director now owns 19,272 shares of the company’s stock, valued at approximately $1,628,484. The disclosure for this sale can be found here. Insiders sold a total of 232,371 shares of company stock worth $19,505,099 in the last 90 days. Insiders own 0.37% of the company’s stock.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.